Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Signs MOU with Taiwan ITRI

6 Aug 2007 07:00

ViaLogy PLC06 August 2007 Date: 6 August 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") Embargoed until: 0700hrs ViaLogy plc Signs Memorandum of Understanding with Taiwan's Industrial Technology Research Institute London, 6 August, 2007 - ViaLogy plc (LSE: VIY), a leading innovator ofreal-time network-centric signal processing platforms, today announces that ithas signed a memorandum of understanding (MOU) with Taiwan's IndustrialTechnology Research Institute (ITRI) to integrate its products, SPMTM andMicroSPMTM, with sensor systems developed by ITRI spin-out companies for uses insafety, security, surveillance and infrastructure management. SPMTM provides a standards-based, sensor-policy engine for managing large-scalenetworks of distributed sensors and systems, including building managementsystems, energy planning and physical security. SPM software allows automatedanalysis, alerting of appropriate personnel and rapid response. MicroSPMTMoffers a high speed hardware platform for fully-autonomous incident-based rapiddetection, analysis and response for sensor and video processing. Using thistechnology, ITRI's products can be enabled to interact rapidly with othernetworked subsystems which support a range of communication protocols. Founded in 1973, ITRI has played a vital role in Taiwan's economic success.Notable ITRI spin-off companies include United Microelectronics Corporation(UMC), the Taiwan Semiconductor Manufacturing Corporation (TSMC), and theVanguard International Semiconductor Company (VIS). Backed by its broadresearch scope and close industrial ties, ITRI is a leader in the globalindustrial R&D community. ITRI has signed research alliances with leadingforeign companies and universities such as Lucent Technologies, Microsoft, MITand the University of California, Berkeley. Michael Kelly, President and CEO of ViaLogy's US subsidiary, commented: "Thiscollaboration is a strategic one for ViaLogy. ITRI has a reputation forcreatively adapting foreign industrial processes to address identified needs andusing these technologies to help its spin-out companies become competitive inworld markets. In today's knowledge-based economy, we believe this cooperationwith ITRI will help position SPM as a comprehensive sensor interoperabilitysolution and service delivery platform for various industries and applicationsacross Asia." Dr. John Mai, ViaLogy's Manager for RFID Platforms, said: "ITRI hasrelationships with the major technology-related businesses in Taiwan. Thiscollaboration will accelerate adoption of SPMTM for large-scale industrialapplications. We are already working on integrating innovative sensor solutionsbeing developed at ITRI to quickly expand and scale up its installed-user base." Dr. Wu Chi Ho, Director of the Power Control and Sensing Application TechnologyDivision, of the Energy and Environmental Research Laboratories within ITRI,commented: "We believe ViaLogy's SPMTM and MicroSPMTM platforms presentexciting solutions to fill gaps in our development and commercialisationprocess. Their IP-enabled sensor interoperability software offers us a path torapidly bring our infrastructure monitoring projects to enterprise-level endusers in the oil and energy market sectors, both within Taiwan andinternationally. "ViaLogy's ability to add new sensors and support new network interoperabilityprotocols within 72 hours is very attractive for our scaling requirements." For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy +44 (0)20 107 8000 About ITRI: The Industrial Technology Research Institute of Taiwan ITRI is a global, non-profit R&D organisation, engaged in applied research andindustrial services. Founded in 1973, ITRI played a vital role in Taiwan'seconomic success and is leading industrial research to transform Taiwan'seconomy from a manufacturing-based one to that of service- and knowledge- based.Backed by its broad research scope and close industrial ties, ITRI is becomingan increasingly active member in the global industrial R&D community. About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Dec 20217:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSNotice of Half-year results
18th Nov 20217:00 amRNSDPYD screening recommended in Spain
28th Oct 20217:00 amRNSRanger® Technology to be presented at Labroots
26th Oct 20217:00 amRNSHalf-year Trading update
29th Sep 20217:00 amRNSResult of AGM
28th Sep 20213:00 pmRNSAGM update
28th Sep 20217:00 amRNSAGM Statement
15th Sep 20217:00 amRNSShare option awards
1st Sep 20217:00 amRNSISO 15189:2012 accreditation received
1st Sep 20217:00 amRNSNotice of AGM and Annual Report 2021
19th Aug 202112:04 pmRNSCOVID-19 Surge testing contract
11th Aug 20217:01 amRNSEarn-out Milestone, Issue of Equity & TVR
11th Aug 20217:00 amRNSAudited Final results&unaudited Q1 business update
6th Aug 20217:00 amRNSConfirmation of Results Date
23rd Jul 20217:00 amRNSNotice of Results
1st Jul 202111:09 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSSecond Strategic Partner for Coastal Genomics
18th Jun 20217:00 amRNSContract Award: DPYD testing kits for NHS Wales
17th Jun 20214:32 pmRNSExercise of Options
9th Jun 20217:00 amRNSMulti-year licence and supply agreement
21st May 20214:30 pmRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSDistribution Partnership
18th May 20217:00 amRNSLaunch of IONA Care NIPT service offering
17th May 20217:00 amRNSFurther testing service agreement for MHC
29th Apr 20217:00 amRNSFull year Trading update
26th Apr 20217:00 amRNSFurther National Microbiology Framework awards
19th Apr 20211:21 pmRNSFurther National Microbiology Framework contract
19th Apr 20217:00 amRNSNational Framework contract award
12th Apr 20217:00 amRNSEarn-out Milestone, Issue of Equity & TVR
6th Apr 20212:43 pmRNSTesting service agreement with MyHealthCheckedplc
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:00 pmRNSCOVID-19 update
23rd Mar 20217:00 amRNSShare option exercises and awards
19th Mar 20217:00 amRNSTwin Pregnancy study published using IONA® Test
17th Mar 20217:00 amRNSAppointment of VP of Sales North America
11th Mar 20217:00 amRNSYourgene Genomic Services portfolio expansion
1st Mar 20217:00 amRNSFirst US Supply Agreement
22nd Feb 20217:00 amRNSPartnership with NPH
10th Feb 202110:51 amRNSCorrection: Director / PDMR Shareholding
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSTrading update
13th Jan 20217:00 amRNSDPYD screening recommended in Belgium
11th Jan 20217:00 amRNSClarigene® SARS-CoV-2 Product Update
8th Jan 20217:00 amRNSIssue of Share Options
24th Dec 20207:00 amRNSCOVID-19 update
17th Dec 20207:00 amRNSHalf-year Report
15th Dec 20207:00 amRNSNotice of Half-year Results
2nd Dec 20207:00 amRNSDPYD kits recommended by NHS England
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.